Compare Liquidia Corporation Common Stock (LQDA) vs Nerdwallet Inc (NRDS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Liquidia Corporation Common Stock vs Nerdwallet Inc — how do they compare? Liquidia Corporation Common Stock trades at $33.69 (market cap $3.04B), while Nerdwallet Inc trades at $9.55 (market cap $610.47M). The key difference: Liquidia Corporation Common Stock is far larger — about 5× Nerdwallet Inc's market cap, and Nerdwallet Inc is more actively traded (506,928 versus 21,111,778). Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Nerdwallet Inc for 45 Days on average.
| LQDA | NRDS | |
|---|---|---|
Market Cap | $3.04B | $610.47M |
Volume | 21,111,778 | 506,928 |
Sector | Health | Media |
52-Week High | $91.03 | $15.93 |
52-Week Low | $22.02 | $7.58 |
Typical Hold Time | 0 Days | 45 Days |
Enterprise Value | $2.94B | $524.77M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
NerdWallet (NRDS) trades at $9.64, down 1.83% today, with strong technical momentum showing 16 bullish signals versus 7 bearish. The company demonstrates solid fundamental improvement with revenue growing from $539M in 2022 to $837M in 2025, while turning profitable with net income reaching $49M. Recent earnings show mixed results with Q2 2026 missing expectations but Q1 and Q4 2025 beating estimates. Valuation metrics appear attractive with P/E of 10.61 and P/S of 0.79, suggesting potential undervaluation relative to growth prospects.
The outlook remains positive with analyst consensus favoring Buy ratings (66.7%) and projecting 27.9% upside potential. Key opportunities include continued revenue growth and margin expansion, while risks involve competitive pressures in financial guidance services and dependence on organic search traffic. The company's improving cash flow generation and strong profitability metrics (18.16% ROE) support the bullish case, though investors should monitor execution on Q3 2026 earnings expectations of $0.35 EPS.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Liquidia Corporation Common Stock
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →About Nerdwallet Inc
Nerdwallet Inc is a free tool to find you the best credit cards, cd rates, savings, checking accounts, scholarships, healthcare and airlines.
Read more on NRDS →
